Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review
- DOI
- 10.3389/fimmu.2026.1985279
- Published
- 2026-10-22
- Container
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1985279,
title = {Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review},
author = {Zhi-Juan Cheng and Shi-Xian Zhou and Zi-Ying He and Ze-Fang Deng and Chuan Zeng and Wei-Ping Chen and Jiang-Long Tu},
year = {2026},
journal = {Frontiers in Immunology},
doi = {10.3389/fimmu.2026.1985279},
url = {https://doi.org/10.3389/fimmu.2026.1985279}
}RIS
TY - JOUR TI - Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review AU - Zhi-Juan Cheng AU - Shi-Xian Zhou AU - Zi-Ying He AU - Ze-Fang Deng AU - Chuan Zeng AU - Wei-Ping Chen AU - Jiang-Long Tu PY - 2026 JO - Frontiers in Immunology DO - 10.3389/fimmu.2026.1985279 UR - https://doi.org/10.3389/fimmu.2026.1985279 ER -
APA
Cheng, Z., Zhou, S., He, Z., Deng, Z., Zeng, C., Chen, W., & Tu, J. (2026). Rapidly progressive cognitive decline and drug-induced encephalopathy secondary to teprotumumab for thyroid eye disease: a case report and narrative literature review. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1985279
Source records
- crossref · retrieved 2026-11-08T14:28:01.736Z